Name | DC_517 |
---|---|
Synonyms |
1-{[1,3-Di(9H-carbazol-9-yl)-2-propanyl]oxy}-3-(isopropylamino)-2-propanol
2-Propanol, 1-[2-(9H-carbazol-9-yl)-1-(9H-carbazol-9-ylmethyl)ethoxy]-3-[(1-methylethyl)amino]- |
Description | DC_517 is a DNA methyltransferase 1 (DNMT1) inhibitor, with an IC50 and a Kd of 1.7 μM and 0.91 μM, respectively. |
---|---|
Related Catalog | |
Target |
DNMT1:0.91 μM (Kd) DNMT1:1.7 μM (IC50) |
In Vitro | DC_517 is a DNA methyltransferase 1 (DNMT1) inhibitor, with an IC50 and a Kd of 1.7 μM and 0.91 μM, respectively. DC_517 (1.25, 2.5, 5, and 10 μM) potently inhibits the proliferation of HCT116 (human colon cancer) and Capan-1 (human pancreatic adenocarcinoma cells) after treatment for 24, 48, and 72 h. DC_517 (0, 0.75, 1.5, and 3 μM) also dose-dependently induces apoptotic cell death in HCT116 cells[1]. |
Kinase Assay | To measure the effects of DC_517 on mouse DNMT1 activity, 200 nM purified DNMT1 is incubated with 200 μM of DC_517 and S-adenosylmethionine (AdoMet) in the DNMT assay buffer in the assay plate at 37°C for 2 h. Next, every sample is incubated with the capture and detection antibody, followed by incubation with developer solution for 10 min at room temperature. The absorbance is measured at 450 nm using a microplate reader. S-Adenosylhomocysteine (AdoHcy) is used as a positive control[1]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 727.9±60.0 °C at 760 mmHg |
Molecular Formula | C33H35N3O2 |
Molecular Weight | 505.650 |
Flash Point | 394.0±32.9 °C |
Exact Mass | 505.272919 |
LogP | 8.26 |
Vapour Pressure | 0.0±2.5 mmHg at 25°C |
Index of Refraction | 1.644 |
Storage condition | 2-8℃ |